Coave Therapeutics lève €32 millions d'euros en série A pour accélérer le développement de ses médicaments génétiques de nouvelle génération
January 09, 2025 03:00 ET
|
Coave Therapeutics
Le tour de table a été mené par Novo Holdings A/S et Bpifrance (dans le cadre de la stratégie d'investissement InnoBio), avec la participation d'investisseurs américains et européens, Invus et UI...
Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines
January 09, 2025 03:00 ET
|
Coave Therapeutics
Financing co-led by Novo Holdings A/S and Bpifrance (as part of the InnoBio investment strategy) and joined by leading US and EU investors Invus and UI Investissement alongside existing...
SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX
September 26, 2024 09:05 ET
|
SciSparc Ltd
The intended selling valuation represents an increase of 47% from the valuation at the time of SciSparc’s initial investment in MitoCareX Bio TEL AVIV, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- ...
With 9.4% CAGR, Central Nervous System Treatment Market Size to Surpass USD 166.53 billion by 2028
December 13, 2023 01:03 ET
|
Fortune Business Insights
Pune, India, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The central nervous system treatment market is expected to grow from USD 89.02 billion in 2021 and poised to achieve a USD 166.53 billion valuation by...
Digital Therapeutics Market Is Projected to Gain $22.60 Billion By 2031, Growing at a 19.4% CAGR: Allied Market Research
October 23, 2023 22:00 ET
|
Allied Market Research
Wilmington, Delaware, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The global digital therapeutics market size was estimated at $3.84 billion and is projected to gain $22.60 billion in 2031, exhibiting a...
Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicated to its Genetic Medicine Delivery Platform
October 12, 2023 07:00 ET
|
Coave Therapeutics
Paris, France, October 12th, 2023– Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies, announces the formation of its new Scientific Advisory Board...
Coave Therapeutics Appoints Genetic Medicine Expert Lolita Petit, PhD as Chief Scientific Officer
September 21, 2023 06:00 ET
|
Coave Therapeutics
Paris, France, September 21, 2023 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies for CNS (Central Nervous System) and eye diseases, announces...
SciSparc Engages Investment Bank to Identify Potential Strategic Transaction Opportunities
September 12, 2023 09:15 ET
|
SciSparc Ltd
TEL AVIV, Israel, Sept. 12, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
Central Nervous System Therapeutics Market to hit USD 238.8 billion by 2032, says Global Market Insights Inc.
August 20, 2023 20:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Aug. 20, 2023 (GLOBE NEWSWIRE) -- Central Nervous System Therapeutics Market size is expected to be worth USD 238.8 billion by 2032. The growing investments in R&D...
Central Nervous System Treatment Market to Surpass 209.2 Billion by 2030 Drives Due to Rising Prevalence of Neurological Disorders
August 11, 2023 10:30 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford,USA, Aug. 11, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest, the Alzheimer's Association reports that approximately 6 million individuals in the United States are presently living with...